These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31791977)

  • 1. Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late Proteins.
    Niu TK; Princiotta MF; Sei JJ; Norbury CC
    Immunohorizons; 2019 Dec; 3(12):559-572. PubMed ID: 31791977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.
    Bonini C; Lee SP; Riddell SR; Greenberg PD
    J Immunol; 2001 Apr; 166(8):5250-7. PubMed ID: 11290810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.
    Moutaftsi M; Bui HH; Peters B; Sidney J; Salek-Ardakani S; Oseroff C; Pasquetto V; Crotty S; Croft M; Lefkowitz EJ; Grey H; Sette A
    J Immunol; 2007 Jun; 178(11):6814-20. PubMed ID: 17513729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia Virus Vectors Targeting Peptides for MHC Class II Presentation to CD4
    Hobbs SJ; Harbour JC; Yates PA; Ortiz D; Landfear SM; Nolz JC
    Immunohorizons; 2020 Jan; 4(1):1-13. PubMed ID: 31896555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.
    Tewalt EF; Grant JM; Granger EL; Palmer DC; Heuss ND; Gregerson DS; Restifo NP; Norbury CC
    PLoS Pathog; 2009 May; 5(5):e1000457. PubMed ID: 19478869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
    Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
    J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
    Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
    J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.
    Davies DH; Chun S; Hermanson G; Tucker JA; Jain A; Nakajima R; Pablo J; Felgner PL; Liang X
    J Immunol; 2014 Aug; 193(4):1812-27. PubMed ID: 25024392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
    Hu Z; Molloy MJ; Usherwood EJ
    Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
    Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
    J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice.
    Larsen IV; Clausius H; Kolb AW; Brandt CR
    J Virol; 2016 Jul; 90(14):6557-6572. PubMed ID: 27170749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.
    Bathke B; Pätzold J; Kassub R; Giessel R; Lämmermann K; Hinterberger M; Brinkmann K; Chaplin P; Suter M; Hochrein H; Lauterbach H
    Immunology; 2018 Jun; 154(2):285-297. PubMed ID: 29281850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovering naturally processed antigenic determinants that confer protective T cell immunity.
    Gilchuk P; Spencer CT; Conant SB; Hill T; Gray JJ; Niu X; Zheng M; Erickson JJ; Boyd KL; McAfee KJ; Oseroff C; Hadrup SR; Bennink JR; Hildebrand W; Edwards KM; Crowe JE; Williams JV; Buus S; Sette A; Schumacher TN; Link AJ; Joyce S
    J Clin Invest; 2013 May; 123(5):1976-87. PubMed ID: 23543059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.
    Kreiter S; Selmi A; Diken M; Sebastian M; Osterloh P; Schild H; Huber C; Türeci O; Sahin U
    J Immunol; 2008 Jan; 180(1):309-18. PubMed ID: 18097032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.
    Rehm KE; Connor RF; Jones GJ; Yimbu K; Mannie MD; Roper RL
    Immunology; 2009 Nov; 128(3):381-92. PubMed ID: 20067538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.
    Heipertz EL; Davies ML; Lin E; Norbury CC
    J Immunol; 2014 Oct; 193(8):4169-77. PubMed ID: 25225666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.